Next Article in Journal
Molecular Cloning and Expression Analysis of P-Selectin from Zebrafish (Danio rerio)
Next Article in Special Issue
Isoprostanes-Biomarkers of Lipid Peroxidation: Their Utility in Evaluating Oxidative Stress and Analysis
Previous Article in Journal
Effect of Oxidative Damage Due to Excessive Protein Ingestion on Pancreas Function in Mice
Previous Article in Special Issue
Proteomic Analysis of Whole Human Saliva Detects Enhanced Expression of Interleukin-1 Receptor Antagonist, Thioredoxin and Lipocalin-1 in Cigarette Smokers Compared to Non-Smokers
Int. J. Mol. Sci. 2010, 11(11), 4601-4617; doi:10.3390/ijms11114601

Biomarker Analysis of Stored Blood Products: Emphasis on Pre-Analytical Issues

1,*  and 1
1 Service Régional Vaudois de Transfusion Sanguine, route de la Corniche 2, CH-1066 Epalinges, Switzerland 2 Faculté de Biologie et Médecine, Université de Lausanne, rue du Bugnon 21, CH-1011 Lausanne, Switzerland
* Author to whom correspondence should be addressed.
Received: 18 October 2010 / Revised: 10 November 2010 / Accepted: 14 November 2010 / Published: 17 November 2010
(This article belongs to the Special Issue Biomarkers)
View Full-Text   |   Download PDF [217 KB, uploaded 19 June 2014]


Millions of blood products are transfused every year; many lives are thus directly concerned by transfusion. The three main labile blood products used in transfusion are erythrocyte concentrates, platelet concentrates and fresh frozen plasma. Each of these products has to be stored according to its particular components. However, during storage, modifications or degradation of those components may occur, and are known as storage lesions. Thus, biomarker discovery of in vivo blood aging as well as in vitro labile blood products storage lesions is of high interest for the transfusion medicine community. Pre-analytical issues are of major importance in analyzing the various blood products during storage conditions as well as according to various protocols that are currently used in blood banks for their preparations. This paper will review key elements that have to be taken into account in the context of proteomic-based biomarker discovery applied to blood banking.
Keywords: labile blood products; aging and storage lesions; biomarkers; pre-analytics; proteomics labile blood products; aging and storage lesions; biomarkers; pre-analytics; proteomics
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Delobel, J.; Rubin, O.; Prudent, M.; Crettaz, D.; Tissot, J.-D.; Lion, N. Biomarker Analysis of Stored Blood Products: Emphasis on Pre-Analytical Issues. Int. J. Mol. Sci. 2010, 11, 4601-4617.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert